Colitis, Ulcerative
215
32
44
117
Key Insights
Highlights
Success Rate
84% trial completion
Published Results
59 trials with published results (27%)
Research Maturity
117 completed trials (54% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
10.7%
23 terminated out of 215 trials
83.6%
-3.0% vs benchmark
22%
47 trials in Phase 3/4
50%
59 of 117 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 117 completed trials
Clinical Trials (215)
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
A Study of Guselkumab in Participants With Crohn's Disease and Ulcerative Colitis
A Real-World Study of Guselkumab in Chinese Participants With Ulcerative Colitis
A Long-term Extension Study of Ustekinumab in Pediatric Participants
A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis
A Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA Therapeutically
A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
A Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn's Disease and Ulcerative Colitis
Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
A Study to Evaluate the Long-Term Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
Characterization of Colorectal Dysplasic Lesions and Stratification of Their Evolving Risk in Inflammatory Bowel Disease Patients: a Prospective, Observational and Multicenter Study
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
Confirmatory Clinical Study in Active Ulcerative Colitis
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
A Study of Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerative Colitis